H2Holdings, Lubo sign MOU for artificial liver

Published: 2012-07-17 06:59:00

Updated: 2012-07-17 06:59:00

H2Holdings, formerly Hepahope Korea, Monday signed a memorandum of understanding (MOU) with Lubo Industrial Inc., a local supplier for automobile machinery parts, to collaborate on the commercialization of a bio-artificial liver system based on pig organs, as the Korean venture company got the go...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK